Transcobalamin II Inhibitors

Chemical inhibitors of Transcobalamin II can interfere with its function in various ways, primarily by targeting its interaction with cobalamin (vitamin B12). Potassium Cyanide forms a strong bond with cobalamin, preventing its association with Transcobalamin II. Mercuric Chloride can engage in complex formation with cobalamin, which impairs the normal interaction between cobalamin and Transcobalamin II. Chloramphenicol inhibits bacterial cobalamin synthase, which can lead to a downstream decrease in cobalamin levels available for Transcobalamin II binding and transport.

Additionally, Sodium Azide disrupts cobalamin metabolism by inhibiting cytochrome c oxidase, which in turn affects its binding to Transcobalamin II. Sodium Nitrite transforms hemoglobin into methemoglobin, which has a higher affinity for cyanide, thereby sequestering cyanide and reducing its binding to cobalamin that is necessary for interaction with Transcobalamin II. N-Ethylmaleimide can alkylate sulfhydryl groups, potentially modifying the cobalamin binding site on Transcobalamin II, leading to inhibition of cobalamin binding. Nitric Oxide can oxidize cobalamin, rendering it unsuitable for binding to Transcobalamin II. Acrylonitrile binds to cobalamin, forming a structure that cannot effectively interact with Transcobalamin II, thus inhibiting the protein's function. Chronic exposure to Ethanol can impair the liver's ability to synthesize cobalamin transport proteins, including Transcobalamin II, reducing its functional presence. Lastly, Cisplatin has the ability to form adducts with cobalamin, which may disrupt the normal interaction between cobalamin and Transcobalamin II, leading to inhibition of the protein's cobalamin transport function.